• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

bristol-myers squibb

  1. What is the real story?

    The last time I was on a Cafepharma message board, was when I worked at BMS. Not that I expect a lot of positive comments from anyone on this site, but seriously what is going on? BMS was always a great place to be a rep. I was displaced during an Orencia restructuring and was not even that...

  2. Amgen to take over Celgene’s OTEZLA for $13.4 billion; BMS increases share buyback

    Bristol-Myers-Squibb announced that Amgen will acquire Celgene’s Otezla business for $13.4 billion in a cash transaction. Bristol-Myers now expects to complete the pending merger with Celgene by the end of 2019. For More:
    • anonymous
    • Thread
    • amgen bristol-myers squibb celgene healthcare otezla pharma
    • Replies: 0
    • Forum: Bristol-Myers Squibb

  3. Celgene posts upbeat Q4 results, guidance

    Celgene Corp. (CELG) swung to a profit in the fourth quarter from a loss last year, helped by lower research and development costs as well as a decline in acquisition-related charges and restructuring. A drop in income tax provision also contributed to the bottom line growth. The results...
    • anonymous
    • Thread
    • bristol-myers squibb celgene
    • Replies: 3
    • Forum: Celgene

  4. Bristol-Myers Squibb swallows Celgene for $74 billion

    Bristol-Myers Squibb acquires Celgene for $74 billion. Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in the pipeline in the biopharma space.
    • anonymous
    • Thread
    • acquisition biopharma bristol-myers squibb buyout celgene merger oncology pharmaceuticals specialty takeover
    • Replies: 3
    • Forum: Celgene

  5. Celgene plunges to new 52-week low

    What's the reason for Celgene going down even after beating the estimates and lifting 2018 outlook? Any thoughts? https://news.alphastreet.com/celgene-celg-stock-q3-2018-earnings/
    • anonymous
    • Thread
    • bristol-myers squibb celgene earnings mark alles merck novartis otezla outlook pharma revlimid
    • Replies: 59
    • Forum: Celgene

  6. Final Post on the BMS board!!

    This is my final post before sitting down to write the book:james Lynchehaun, my war on terror. The book will have a copy of my passport with the relevant dates shown. I worked for ConvaTec in their Deeside plant, in a unit that was managed by, amongst others, Robbie Heginbotham. I had...
    • Anonymous
    • Thread
    • bristol-myers squibb convatec awc deeside corruption whistleblowers
    • Replies: 20
    • Forum: Bristol-Myers Squibb
Top Bottom
Back